XDH and hyperuricemia: The results of our study bring important information for further research as well as for care for patients with HF and hyperuricemia: generally administered xanthine oxidase inhibition by allopurinol at a low dose of 100 mg has no impact on the prognosis of HF patients with hyperuricemia (UA ≥500 μmoL/L).